| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/22/2002 | US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/22/2002 | US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease |
| 08/22/2002 | US20020115143 Expression vector coding immunoglobulin for use in the of infections and cancer |
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020114852 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 08/22/2002 | US20020114842 Use of amoxycillin and clavulanate in the manufacture of a medicament for the empiric treatment of infections caused by drug-resistant streptococcus pneumo-nia |
| 08/22/2002 | US20020114818 DNA sequence coated onto carrier particle, DNA sequence comprising promoter operative in cells of a mammal and a protein coding region coding for determinant of hantavirus protein |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | US20020114778 Comprises ethylene oxide-propylene oxide block copolymer providing viscosity and hydroxypropyl methylcellulose improving durability, for moisturizing and lubricating eye drops containing opthalmic drugs |
| 08/22/2002 | US20020114777 Cationic quaternery ammonium containing polymers for treatment of gastrointestinal disorders; cytotoxicity |
| 08/22/2002 | US20020114776 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 08/22/2002 | DE10106647A1 Ratjadon-Derivate zum Hemmen des Zellwachstums Ratjadone derivatives for inhibiting cell growth |
| 08/22/2002 | CA2438515A1 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | CA2437890A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | CA2437864A1 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | CA2437823A1 Acrochordon alleviation |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/22/2002 | CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/21/2002 | EP1233062A2 Destabilisation of viral quasi-species distributions - avoiding resistance phenomena |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233022A1 Acellular pertussis vaccines and methods of preparation thereof |
| 08/21/2002 | EP1232758A1 Polynucleotide formulated for improved intracellular transfer |
| 08/21/2002 | EP1232755A2 Anti-HIV agents |
| 08/21/2002 | EP1232754A2 Use of cationic helix peptides for treatment of sepsis and for detection and removal of endotoxins |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232267A2 Activation of hcv-specific t cells |
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232257A2 Modular transport systems for molecular substances and production and use thereof |
| 08/21/2002 | EP1232249A1 Duck pneumovirus and corresponding vaccines |
| 08/21/2002 | EP1232248A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 08/21/2002 | EP1232184A1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof |
| 08/21/2002 | EP1232181A2 Recombinant gelatins |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232173A1 Fusidic acid derivatives |
| 08/21/2002 | EP1232171A1 Method of preparing clarithromycin |
| 08/21/2002 | EP1232169A1 Gallotannins and ellagitannins as regulators of cytokine release |
| 08/21/2002 | EP1232167A1 Synthetic oligomannosides, preparation and uses thereof |
| 08/21/2002 | EP1232148A1 Use of benzotriazole uv absorbers |
| 08/21/2002 | EP1232147A1 Triazoles as farnesyl transferase inhibitors |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231948A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 08/21/2002 | EP1231940A1 Stable amorphous amifostine composition, and preparation thereof |
| 08/21/2002 | EP1231933A1 An aqueous solution formulation of alpha-interferon |
| 08/21/2002 | EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 08/21/2002 | EP1231929A1 Antiviral composition |
| 08/21/2002 | EP1231925A1 Method and composition for the treatment of adenoviral ocular infections |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP1231915A1 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 08/21/2002 | EP1231903A2 Coating of tablet cores |
| 08/21/2002 | EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 08/21/2002 | EP0900797B1 A 1-methylcarbapenem derivative |
| 08/21/2002 | EP0866654A4 Method for treating hepatitis virus infection |
| 08/21/2002 | EP0804456B1 Peptide nucleic acid conjugates |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365365A Process for preparing a charcoal-GM1 complex |
| 08/21/2002 | CN1365286A Method for treating chronic HBV infection |
| 08/21/2002 | CN1365280A 抗菌化合物 Antibacterial compounds |
| 08/21/2002 | CN1364898A Process for preparing target ribonuclease for curing hepatitis B virus infection |
| 08/21/2002 | CN1364644A Immuno liposome therapeutic hepatitis B vaccine and its preparing method |
| 08/21/2002 | CN1364639A Medicine for inhibiting HIV virus from spreading |
| 08/21/2002 | CN1364638A Health article for preventing HIV virus |
| 08/21/2002 | CN1364620A Tinea clearing away liquid |
| 08/21/2002 | CN1364613A Veterinary medicine |
| 08/21/2002 | CN1364600A Nano asthma arresting medicine and its preparing method |
| 08/21/2002 | CN1364596A Nano mulberry leaf-ginger common cold treating medicine and its preparing method |
| 08/21/2002 | CN1364579A Nano Children Zhibao medicine and its preparing method |
| 08/21/2002 | CN1364556A Nano Liangge scan medicine and its preparing method |
| 08/21/2002 | CN1364554A Nano Long eliminating medicine and its preparing method |
| 08/21/2002 | CN1364547A Nano Tongxuanlifei medicine and its preparing method |
| 08/21/2002 | CN1364544A Nano Xinxue medicine and its preparing method |
| 08/21/2002 | CN1364543A Nano apricot kernel and perilla antitussive medicine and its preparing method |
| 08/21/2002 | CN1364539A Nano Yushusan medicine and its preparing method |
| 08/21/2002 | CN1364518A Nano pittecellobium clypearia Benth anti-imflammatory medicine and its preparing method |
| 08/21/2002 | CN1364491A Nano twelve imgredient hooker winghead root medicine and its preparing method |
| 08/21/2002 | CN1364472A Nano five ingredient musk medicine and its preparing method |
| 08/21/2002 | CN1364467A Antiphlogistic liquid |
| 08/21/2002 | CN1364463A Berberis poiretii schneid detoxicating and inflammation diminishing tablet and its preparing process |
| 08/21/2002 | CN1089370C Recombination vaccinia virus for expression of measles virus L4 strain hemagglutini and fusion protein gene |
| 08/21/2002 | CN1089247C Styptic and inflammation-relieving medicine and its preparing process |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437134 Silylating the corresponding carbamate compound; alkylation |
| 08/20/2002 | US6437125 Process for the production of purine derivatives |
| 08/20/2002 | US6437119 Forming acid chloride of nalidixic acid, perfloxacin, or ofloxacin with thionyl chloride, condensing with betalactam, intermediate reacts with triaryl phosphine and carbon tetrachloride, then tetracycline, metronidazole, chloramphen |
| 08/20/2002 | US6437106 Alkylation with alkenyl carbonate or carbamate in presence of palladium catalyst and phosphine; cyclization |
| 08/20/2002 | US6436991 Composition and method containing products extracted from Commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease |